PTGS2 and prostate cancer: Similarly, Fradet and co-workers found men with the COX-2 variant rs4648310 (+8897 A/G) to be at increased risk for prostate cancer when intake of n-3 LC-PUFA was low, but higher n-3 LC-PUFA intake was strongly protective [15].